English
 

Qiang Xu

Qiang Xu, Ph.D.
Partner

Dr. Qiang Xu is a Partner at Decheng Capital and has been with the firm since its inception. He is currently serving on the boards of BCFoods, GYT HealthCare Services, IMPACT Therapeutics, KeChow Pharma and Kind Pharmaceutical.

He has over 14 years of experience from biotechnology start-ups to pharmaceutical companies and also has extensive experience in agricultural biotechnology. He was most recently Vice President of Research at Osel and the principal investigator for multiple grants funded by the NIH and other foundations. Dr. Xu started his biotechnology career at Bayer, worked at Pan Pacific Pharmaceuticals as a director, and Scios as a member of the Alzheimers Disease Discovery Program. He has published over 30 peer reviewed papers, and 50 conference presentations, and is the co-inventor of 10 patents or applications. Dr. Xu received his BS in agronomy and MS in Crop Sciences (with Professor Yu Songlie, an academician of the Chinese Academy of Engineering) and PhD in plant physiology from Kansas State University. He completed his postdoctoral training at the University of California, Berkeley.

 

Min Cui, Ph.D.
Managing Director
Victor E. Tong, Jr.
Partner
Nick Pliam, M.D., Ph.D.
Partner
Y. Katherine Xu, Ph.D.
Partner
Qiang Xu, Ph.D.
Partner
Wei Xu
Partner
Peter Colabuono
Principal
Tony Tong, Ph.D.
Principal

Claire Chin, M.D., MBA
Associate

Aaron Li, MBA
Associate
Yang Lu, MBA
Associate
Dan Zabrowski, Ph.D.
Venture Partner
Copyright © 2011 Decheng Capital LLC. All Rights Reserved.